EFFICACY AND SAFETY OF EMAPALUMAB, A FULLY HUMAN, ANTI-INTERFERON GAMMA MONOCLONAL ANTIBODY, DESCRIBED IN TREATMENT-NAIVE PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS

被引:0
|
作者
Locatelli, Franco [1 ,2 ]
Jordan, Michael [3 ,4 ,5 ]
Allen, Carl [6 ]
Cesaro, Simone [7 ]
Rizzari, Carmelo [8 ]
Rao, Anupama [9 ]
Degar, Barbara [10 ]
Garrington, Timothy [11 ]
Sevilla, Julian [12 ,13 ]
Putti, Maria Caterina [14 ]
Fagioli, Franca [15 ]
Ahlmann, Martina [16 ]
Dapena Diaz, Jose-Luis [17 ]
Henry, Michael [18 ]
De Benedetti, Fabrizio [19 ]
Grom, Alexei [20 ]
Jacqmin, Philippe [21 ]
Ballabio, Maria [22 ]
de Min, Cristina [23 ]
机构
[1] Sapienza Univ Rome, Dept Pediat, Rome, Italy
[2] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol, Rome, Italy
[3] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA
[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA
[5] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[6] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[7] Azienda Osped Univ Integrata, Woman & Child Hosp, Pediat Hematol Oncol, Verona, Italy
[8] Univ Milano Bicocca, Pediat Hematol Oncol Unit, Monza Brianza Bambino Mamma Fdn, Monza, Italy
[9] Great Ormond St Hosp Sick Children, Dept Hematol, London, England
[10] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Hematol Oncol, Boston, MA USA
[11] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
[12] Fdn Invest Biomed Hosp Infantil Univ Nino Jesus, Ctr Invest Biomed Red Enfermedades Raras, Dept Pediat Hematol Oncol, Madrid, Spain
[13] Fdn Invest Biomed Hosp Infantil Univ Nino Jesus, Ctr Invest Biomed Red Enfermedades Raras, Dept Hematol & Oncol, Madrid, Spain
[14] Univ Hosp Padova, Clin Pediat Hematol Oncol, Padua, Italy
[15] Regina Margherita Hosp, Div Pediat Oncohematol, Turin, Italy
[16] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, Munster, Germany
[17] Hosp Univ Vall dHebron, Dept Pediat Hematol & Oncol, Barcelona, Spain
[18] Phoenix Childrens Hosp, Ctr Canc & Blood Disorders, Phoenix, AZ USA
[19] IRCCS Bambino Gesu Childrens Hosp, Div Rheumatol, Rome, Italy
[20] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA
[21] MnS Modelling & Simulat, Dinant, Belgium
[22] Swedish Orphan BiovitrumAG Sobi, Basel, Switzerland
[23] Swedish Orphan Biovitrum AG Sobi, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] ANTI INTERFERON-GAMMA (IFNγ) MONOCLONAL ANTIBODY TREATMENT IN A CHILD WITH NLRC4-RELATED DISEASE AND SEVERE HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
    Bracaglia, Claudia
    Prencipe, Giusi
    Gatto, Antonio
    Pardeo, Manuela
    Lapeyre, Genevieve
    Raganelli, Luigi
    Marasco, Emiliano
    Ferlin, Walter
    Nelson, Robert
    de Min, Cristina
    de Benedetti, Fabrizio
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S123 - S123
  • [22] Anti Interferon-Gamma (IFNg) Monoclonal Antibody Treatment in a Child with NLRC4-Related Disease and Severe Hemophagocytic Lymphohistiocytosis (HLH)
    Bracaglia, Claudia
    Prencipe, Giusi
    Gatto, Antonio
    Pardeo, Manuela
    Lapeyre, Genevieve
    Raganelli, Luigi
    Marasco, Emiliano
    Insalaco, Antonella
    Ferlin, Walter
    Nelson, Robert
    de Min, Cristina
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
    Ramos, Eleanor L.
    Mitcham, Jennifer L.
    Koller, Teri D.
    Bonavia, Aurelio
    Usner, Dale W.
    Balaratnam, Ganesh
    Fredlund, Paul
    Swiderek, Kristine M.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (07): : 1038 - 1044
  • [24] A Phase 1b Study Evaluating the Safety and Efficacy of AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine in Patients with Treatment-Naive Acute Myeloid Leukemia
    Wang, Huafeng
    Zhang, Qike
    Teng, Qingliang
    Li, Zhenyu
    Liu, Hong
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Yu
    Jin, Jie
    BLOOD, 2023, 142
  • [25] Pharmacokinetics, efficacy, and safety of weekly/biweekly dosing of Xembify® in treatment-experienced patients, and loading/maintenance dosing in treatment-naive patients with primary immunodeficiency
    Lumry, William
    Palumbo, Michael
    Hsu, Connie
    Hussain, Iftikhar
    McNeil, Donald
    Bridges, Tracy
    Scarupa, Mark
    Mondou, Elsa
    Nanaware-Kharade, Nisha
    Hanna, Kim
    Liang, Jin
    Williamson, Jennifer
    Querolt-Coll, Montserrat
    Oliveras, Juan
    CLINICAL IMMUNOLOGY, 2024, 262
  • [26] Aumolertinib in Treatment-Naive EGFR-mutant NSCLC Patients With Brain Metastases: Primary Efficacy and Safety Data from the ARTISTRY
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S397 - S398
  • [27] A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment
    Byun, Ja Min
    Kim, Ho Young
    Nam, Seung-Hyun
    Shin, Ho-Jin
    Song, Seulki
    Park, Jinny
    Han, Sang Hoon
    Park, Yong
    Yuh, Young Jin
    Mun, Yeung-Chul
    Do, Young Rok
    Sohn, Sang Kyun
    Bae, Sung Hwa
    Shin, Dong-Yeop
    Yoon, Sung-Soo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus
    Werth, Victoria P.
    Fiorentino, David
    Sullivan, Barbara A.
    Boedigheimer, Michael J.
    Chiu, Kit
    Wang, Christine
    Arnold, Gregory E.
    Damore, Michael A.
    Bigler, Jeannette
    Welcher, Andrew A.
    Russell, Chris B.
    Martin, David A.
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) : 1028 - 1034
  • [29] Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2A in treatment-naive patients with chronic hepatitis C and HCV genotype 1
    Desch, S
    Vaeth, T
    Tamba, M
    Klinker, H
    Langmann, P
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2001, 6 (06) : 242 - 246
  • [30] Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophihc syndrome
    Klion, AD
    Law, MA
    Noel, P
    Kim, YJ
    Haverty, TP
    Nutman, TB
    BLOOD, 2004, 103 (08) : 2939 - 2941